A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor

Peptides

Volumn 31, Issue 7, 2010, Pages 1400-1404

  Gingell, Joseph J ^a   Qi, Tao ^a   Bailey, Richard J ^a   Hay, Debbie L ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLIN 1 RECEPTOR; ARGININE; ASPARAGINE; BINDING PROTEIN; GLUTAMIC ACID; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOLYSIS; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; RATS; RECEPTORS, PEPTIDE; TRANSFECTION; TRYPTOPHAN;

EID: 77952581108     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.027     Document Type: Article

References (23)

1. Bailey R.J., and Hay D.L. Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27 (2006) 1367-1375
2. Bailey R.J., and Hay D.L. Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor. Br J Pharmacol 151 (2007) 678-687
3. Dong M., Cox R.F., and Miller L.J. Juxtamembranous region of the amino terminus of the family B G protein-coupled calcitonin receptor plays a critical role in small-molecule agonist action. J Biol Chem 284 (2009) 21839-21847
4. Hay D.L., Christopoulos G., Christopoulos A., Poyner D.R., and Sexton P.M. Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol Pharmacol 67 (2005) 1655-1665
5. Hay D.L., Christopoulos G., Christopoulos A., and Sexton P.M. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]- 1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo -3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors - the role of receptor activity modifying protein 1. Mol Pharmacol 70 (2006) 1984-1991
6. Hoare S.R. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 10 (2005) 417-427
7. Koth C.M., Abdul-Manan N., Lepre C.A., Connolly P.J., Yoo S., Mohanty A.K., et al. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor. Biochemistry 49 (2010) 1862-1872
8. Kusano S., Kukimoto-Niino M., Akasaka R., Toyama M., Terada T., Shirouzu M., et al. Crystal structure of the human receptor activity-modifying protein 1 extracellular domain. Protein Sci 17 (2008) 1907-1914
9. Kuwasako K., Cao Y.N., Nagoshi Y., Tsuruda T., Kitamura K., and Eto T. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins. Mol Pharmacol 65 (2004) 207-213
10. Lutz T.A. Amylinergic control of food intake. Physiol Behav 89 (2006) 465-471
11. Mallee J.J., Salvatore C.A., LeBourdelles B., Oliver K.R., Longmore J., Koblan K.S., et al. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277 (2002) 14294-14298
12. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
13. Moore E.L., Gingell J.J., Kane S.A., Hay D.L., and Salvatore C.A. Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. Biochem Biophys Res Commun 394 (2010) 141-145
14. Pham V., Wade J.D., Purdue B.W., and Sexton P.M. Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor. J Biol Chem 279 (2004) 6720-6729
15. Pham V., Dong M., Wade J.D., Miller L.J., Morton C.J., Ng H.L., et al. Insights into interactions between the alpha-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling. J Biol Chem 280 (2005) 28610-28622
16. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., et al. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54 (2002) 233-246
17. Qi T., Christopoulos G., Bailey R.J., Christopoulos A., Sexton P.M., and Hay D.L. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Mol Pharmacol 74 (2008) 1059-1071
18. Qi T., Simms J., Bailey R.J., Wheatley M., Rathbone D.L., Hay D.L., et al. Structure-function analysis of RAMP1-RAMP3 chimeras. Biochemistry 49 (2009) 522-531
19. Ryan G.J., Jobe L.J., and Martin R. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus. Clin Ther 27 (2005) 1500-1512
20. Sexton P.M., Poyner D.R., Simms J., Christopoulos A., Hay D.L., and Modulating receptor function through RAMPs: can they represent drug targets in themselves?. Drug Discov Today 14 (2009) 413-419
21. Simms J., Hay D.L., Bailey R.J., Konycheva G., Bailey G., Wheatley M., et al. Structure-function analysis of RAMP1 by alanine mutagenesis. Biochemistry 48 (2009) 198-205
22. Westermark P., Engstrom U., Johnson K.H., Westermark G.T., and Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87 (1990) 5036-5040
23. Wookey P.J., Lutz T.A., and Andrikopoulos S. Amylin in the periphery II: an updated mini-review. ScientificWorldJournal 6 (2006) 1642-1655